Detection of discordant HER2 status by FISH in circulating tumor cells and disseminated tumor cells in early-stage breast cancer using a microfluidic-based cell enrichment and extraction platform (OncoCEE).

Authors

null

Savitri Krishnamurthy

University of Texas M. D. Anderson Cancer Center, Houston, TX

Savitri Krishnamurthy , Farideh Z. Bischoff , Julie Ann Mayer , Henry Mark Kuerer , Ashutosh Lodhi , Anirban Bhattacharyya , Carolyn S. Hall , Karina Wong , Tam Pham , Tony J Pircher , Anthony Lucci Jr.

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2012 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Tumor Biology

Track

Tumor Biology

Sub Track

Circulating Tumor Cells

Citation

J Clin Oncol 30, 2012 (suppl; abstr TPS10631)

DOI

10.1200/jco.2012.30.15_suppl.tps10631

Abstract #

TPS10631

Poster Bd #

53H

Abstract Disclosures

Similar Posters

Poster

2023 ASCO Annual Meeting

Do HER2 low tumors have a distinct clinicopathologic phenotype?

Do HER2 low tumors have a distinct clinicopathologic phenotype?

First Author: Natália Polidorio

Poster

2023 ASCO Annual Meeting

HER2-low breast cancer brain metastases: Incidence and treatment implications.

HER2-low breast cancer brain metastases: Incidence and treatment implications.

First Author: Rania Chehade